Salicylic acid

Description

The product is identified by the SPL code 34089-3. No additional specific description details are provided in the available text.

Uses and Indications

This drug is indicated for the removal of common and plantar warts. Common warts are characterized by their rough, 'cauliflower-like' appearance on the surface, while plantar warts are identified by their location exclusively on the bottom of the foot, tenderness, and disruption of the footprint pattern.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

The affected area, including corns or warts, should be washed with warm water prior to treatment. After cleansing, the skin must be thoroughly dried.

To prepare the medication, the inner plug should be removed from the bottle. The brush must then be installed into the bottle cap, ensuring it is pressed tightly, followed by securely tightening the cap on the bottle.

Once prepared, the cap can be opened, and the brush should be dipped into the liquid. The liquid is to be applied directly to the wart or corn. After the initial application, the liquid will dry and form a mask. A second application of the liquid should be made once the first layer has dried.

This procedure may be repeated once or twice daily as necessary, continuing until the wart or corn is removed, for a maximum duration of 12 weeks.

Contraindications

Use of this product is contraindicated in the following situations:

Application on damaged skin, including cuts, abrasions, eczema, or sunburn, is prohibited due to the potential for increased irritation and adverse reactions.

Patients with known allergies to any of the product's ingredients should not use it, as this may lead to severe allergic reactions.

The product is also contraindicated in pregnant or breastfeeding individuals, as safety during these conditions has not been established.

Additionally, the product should be discontinued if discomfort persists. Caution is advised for individuals with diabetes or poor blood circulation, as these conditions may exacerbate adverse effects.

Warnings and Precautions

For external use only. This product should not be applied to irritated skin or any area that is infected or reddened. It is contraindicated for use on moles, birthmarks, warts with hairs growing from them, genital warts, or warts located on the face or mucous membranes.

Healthcare professionals should advise patients to consult a doctor prior to use if they have diabetes or poor blood circulation. During application, it is crucial to avoid contact with the eyes. In the event of accidental exposure to the eyes, the affected area should be flushed with water for 15 minutes. Additionally, inhalation of vapors should be avoided to prevent respiratory irritation.

Patients should be instructed to discontinue use and seek medical advice if discomfort persists. The product is extremely flammable; therefore, it must be kept away from fire and flame. The bottle should be tightly capped and stored at room temperature, away from heat sources.

It is essential to keep this product out of reach of children. In case of ingestion, immediate medical assistance should be sought, or the Poison Control Center should be contacted at 1-800-222-1222. Patients should also be advised to stop use if discomfort continues or if they have diabetes or poor blood circulation.

Side Effects

Patients using this product should be aware that it is intended for external use only and must not be applied to irritated skin or any area that is infected or reddened. It is contraindicated for use on moles, birthmarks, warts with hairs growing from them, genital warts, or warts located on the face or mucous membranes.

Participants are advised to consult a healthcare professional prior to use if they have diabetes or poor blood circulation. During application, it is crucial to avoid contact with the eyes; in the event of exposure, the affected area should be flushed with water for 15 minutes. Additionally, inhalation of vapors should be avoided, and the product is classified as extremely flammable, necessitating careful storage away from fire and flame. The bottle should be tightly capped and stored at room temperature, away from heat sources, and kept out of reach of children.

If the product is ingested, immediate medical assistance should be sought, or the Poison Control Center should be contacted. Discomfort may persist if the product is used inappropriately or on contraindicated areas, and patients are advised to discontinue use and consult a doctor if discomfort continues.

Drug Interactions

There are currently no documented drug interactions associated with this medication. Additionally, there is no information available regarding interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are warranted at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Wart Remove. Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep this medication out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center is recommended.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any potential adverse effects or changes in efficacy, given the lack of targeted data for this population.

Pregnancy

Pregnant patients and those who are breastfeeding should not use this medication. The potential risks associated with the use of this drug during pregnancy have not been established, and its safety profile in lactating women is also unclear. Healthcare professionals are advised to consider alternative treatments for women who are pregnant or breastfeeding to avoid any potential adverse effects on fetal outcomes or infant health.

Lactation

Lactating mothers are advised against the use of this medication while breastfeeding. There is no available data on the excretion of this drug in human breast milk or its effects on breastfed infants. Therefore, caution is warranted, and alternative treatments should be considered for lactating mothers.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available data regarding dosage adjustments, special monitoring, or safety considerations. Therefore, healthcare professionals should exercise caution when prescribing this medication to patients with reduced kidney function, as the lack of information necessitates careful clinical judgment and monitoring.

Hepatic Impairment

There is no information available regarding the use of this medication in patients with hepatic impairment. Consequently, there are no dosage adjustments, special monitoring requirements, or precautions specified for individuals with compromised liver function. Healthcare professionals should exercise clinical judgment when considering the use of this medication in patients with liver problems, as the absence of specific guidance necessitates careful evaluation of the patient's overall health status and liver function.

Overdosage

In the event of an overdosage, immediate medical intervention is crucial. If the substance is ingested, healthcare professionals should advise patients or caregivers to seek medical assistance or contact the Poison Control Center without delay.

Prompt action is essential to mitigate potential adverse effects associated with overdosage. Symptoms may vary depending on the specific substance involved; therefore, a thorough assessment by a medical professional is recommended to determine the appropriate management strategy.

Healthcare providers should be prepared to implement supportive care and symptomatic treatment as necessary, based on the clinical presentation of the patient. Continuous monitoring and evaluation may be required to ensure patient safety and effective management of any complications arising from the overdosage.

Nonclinical Toxicology

The use of this product is contraindicated in pregnant or breastfeeding individuals due to potential teratogenic effects. Currently, there is no available data regarding non-teratogenic effects. Additionally, there is no information provided in the nonclinical toxicology section, nor is there any data available concerning animal pharmacology and toxicology.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep this product out of reach of children. In the event of accidental ingestion, patients should seek medical assistance or contact a Poison Control Center immediately.

Patients should be informed that if discomfort persists after using the product, they should consult their healthcare provider for further evaluation and guidance.

It is important for healthcare providers to discuss the use of this product with patients who have diabetes or poor blood circulation, as these conditions may affect the safety and efficacy of the treatment.

Additionally, patients should be instructed to avoid contact with the eyes, ears, and mouth while using this product. In the case of accidental contact with the eyes, patients should rinse their eyes thoroughly with water and seek medical attention if irritation continues.

Storage and Handling

There is currently no data available regarding the supply configurations or storage and handling conditions for this product.

Additional Clinical Information

The medication is administered topically, with the recommended frequency being once or twice daily as needed until the wart is removed, for a maximum duration of 12 weeks. There are no additional details available regarding laboratory tests, abuse information, patient counseling, or postmarketing experience.

Drug Information (PDF)

This file contains official product information for Wart Remove, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)